$NBIO "There are significant unmet medical needs i
Post# of 1377
(Total Views: 215)
Posted On: 03/08/2022 9:11:59 AM
$NBIO
Quote:
"There are significant unmet medical needs in a variety of cancers," said Sean Carrick, CEO of Nascent Biotech, makers of the immunotherapy treatment. "Nascent is committed to changing patient expectations and outcomes in one of the world's most debilitating cancers and Sharp is a valuable partner towards achieving this goal. We're highly encouraged by the potential of Pritumumab to deliver an innovative, first-in-class treatment option, and we are delighted to be working closely with the Laurel Amtower Cancer Institute and Neuro-Oncology Center at Sharp HealthCare for this study."
(0)
(0)Scroll down for more posts ▼